Steward Partners Investment Advisory, LLC Aurinia Pharmaceuticals Inc. Transaction History

Steward Partners Investment Advisory, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$17.78 - $33.08 $8,890 - $16,540	-500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $5,465 - $11,775	500 New	500 $11,000
Q2 2021 Aug 13, 2021	SELL	$10.0 - $14.52 $17,000 - $24,684	-1,700 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$12.3 - $18.73 $20,910 - $31,841	1,700 New	1,700 $22,000
Q2 2020 Aug 06, 2020	SELL	$14.12 - $18.33 $28,240 - $36,660	-2,000 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$11.34 - $21.46 $2,268 - $4,292	-200 Reduced 9.09%	2,000 $29,000
Q4 2019 Jan 17, 2020	BUY	$3.88 - $21.42 $6,596 - $36,414	1,700 Added 340.0%	2,200 $44,000
Q2 2019 Jul 25, 2019	BUY	$6.05 - $6.75 $3,025 - $3,375	500 New	500 $3,000
Q4 2018 Jan 15, 2019	SELL	$5.08 - $6.83 $2,540 - $3,415	-500 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$4.85 - $5.99 $2,425 - $2,995	500 New	500 $2,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.